150 related articles for article (PubMed ID: 7594640)
1. Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity.
Peltonen J; Karvonen SL; Ylä-Outinen H; Hirvonen O; Karvonen J
J Invest Dermatol; 1995 Nov; 105(5):664-7. PubMed ID: 7594640
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies.
Hermonen J; Hirvonen O; Ylä-Outinen H; Lakkakorpi J; Björkstrand AS; Laurikainen L; Kallioinen M; Oikarinen A; Peltonen S; Peltonen J
Lab Invest; 1995 Aug; 73(2):221-8. PubMed ID: 7637322
[TBL] [Abstract][Full Text] [Related]
3. Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression.
Endo H; Momota Y; Oikawa A; Shinkai H
Br J Dermatol; 2006 Apr; 154(4):619-23. PubMed ID: 16536802
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of protein kinase C isoenzymes in normal and psoriatic adult human skin: reduced expression of protein kinase C-beta II in psoriasis.
Fisher GJ; Tavakkol A; Leach K; Burns D; Basta P; Loomis C; Griffiths CE; Cooper KD; Reynolds NJ; Elder JT
J Invest Dermatol; 1993 Oct; 101(4):553-9. PubMed ID: 8409523
[TBL] [Abstract][Full Text] [Related]
5. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.
Groves RW; Sherman L; Mizutani H; Dower SK; Kupper TS
Am J Pathol; 1994 Nov; 145(5):1048-56. PubMed ID: 7977638
[TBL] [Abstract][Full Text] [Related]
6. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.
Karvonen SL; Koivunen J; Nissinen M; Ylä-Outinen H; Björkstrand AS; Peltonen J
Br J Dermatol; 2004 Feb; 150(2):211-9. PubMed ID: 14996090
[TBL] [Abstract][Full Text] [Related]
9. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
[TBL] [Abstract][Full Text] [Related]
10. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.
Tervaniemi MH; Katayama S; Skoog T; Siitonen HA; Vuola J; Nuutila K; Sormunen R; Johnsson A; Linnarsson S; Suomela S; Kankuri E; Kere J; Elomaa O
Sci Rep; 2016 Mar; 6():22745. PubMed ID: 26976200
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz BS; Michel G; Wagner S; Süss R; Beetz A; Peter RU; Kemény L; Ruzicka T
J Immunol; 1993 Oct; 151(8):4399-406. PubMed ID: 7691948
[TBL] [Abstract][Full Text] [Related]
12. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
Alessandrini F; Stachowitz S; Ring J; Behrendt H
J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
[TBL] [Abstract][Full Text] [Related]
13. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
14. Expression and Function of VEGFRs in Normal Epidermis and Psoriatic Lesional Keratinocytes.
Wang Y; Yan Y; Yu H; Jiang G; Zhao S; Yi M
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):50-56. PubMed ID: 37715429
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
16. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.
Kojima T; Cromie MA; Fisher GJ; Voorhees JJ; Elder JT
J Invest Dermatol; 1993 Dec; 101(6):767-72. PubMed ID: 8245503
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-12 is increased in psoriatic skin.
Yawalkar N; Karlen S; Hunger R; Brand CU; Braathen LR
J Invest Dermatol; 1998 Dec; 111(6):1053-7. PubMed ID: 9856816
[TBL] [Abstract][Full Text] [Related]
18. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
19. Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.
Malhotra R; Ratner N
J Invest Dermatol; 1994 May; 102(5):812-8. PubMed ID: 8176268
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing.
Sobolev VV; Mezentsev AV; Ziganshin RH; Soboleva AG; Denieva M; Korsunskaya IM; Svitich OA
PLoS One; 2021; 16(5):e0240956. PubMed ID: 34038424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
